Search
for

    Sort by

    Research 151–180 of 671

    1. Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata 2015
    2. Abstract P5-21-05: ERALOP study: Post adjuvant FEC - docetaxel chemotherapy for early breast cancer: Hair regrowth in the real life Cancer research · 2015
    3. 피나스테라이드의 특성에 대한 이론적 연구 한국산업융합학회 논문집 · 2013
    4. 1746 INCREASED SERUM C-REACTIVE PROTEIN LEVELS IMPLIES CHRONIC INFLAMMATION IS INVOLVED IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND PREDOMINANT STORAGE LOWER URINARY TRACT SYMPTOMS The Journal of Urology · 2013
    5. Glatze in jungen Jahren könnte Risikofaktor für BPH sein Uro-News · 2012
    6. 1449 PROSTATE CANCER PATIENTS WITH METABOLIC SYNDROME SHOWED LOW GRADE GLEASON SCORE WHEN DIAGNOSED ON BIOPSY The Journal of Urology · 2012
    7. S1 OPIOID RECEPTOR AGONISTS AND SERUM PROSTATE SPECIFIC ANTIGENE LEVEL: IS THERE A ROLE FOR PROSTATE CANCER CONTROL AND CHEMOPREVENTION? European Urology Supplements · 2010
    8. S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER? European Urology Supplements · 2010
    9. DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP The Journal of Urology · 2009
    10. NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS The Journal of Urology · 2009
    11. CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT? The Journal of Urology · 2009
    12. The influence of secoisolariciresinol diglusoside on non-emasculated rat in BPH Journal of Jilin Medical College · 2009
    13. Urological Oncology: Prostate Cancer The Journal of Urology · 2008
    14. 토마토 추출액 복합체가 전립선 암 세포와 전립선 비대증에 미치는 영향 생약학회지 · 2007
    15. Urological Oncology: Testis Cancer and Advances in Oncological Therapy The Journal of Urology · 2007
    16. Faculty Opinions recommendation of Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2007
    17. Editorial comment 1 Urology · 2004
    18. 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy Open MIND · 2026
    19. Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese Research Square (Research Square) · 2023
    20. Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele Cancer Causes & Control · 2017
    21. 1378 CHARATERISTICS OF PATIENTS ON NON-DAILY AND DAILY DUTASTERIDE COMPARED TO PATIENTS CYTOREDUCTION NAIVE The Journal of Urology · 2013
    22. Total prostate volume as risk factor for semen pathologies in ageing male Journal of Men's Health · 2010
    23. S89 Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8) European Urology Supplements · 2009
    24. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    25. PCPT Results Could Affect Trial on Testosterone Replacement Oncology Times · 2003
    26. IMPLICAÇÕES DA TOMA CRÓNICA DA FINASTERIDE PARA A ALOPÉCIA ANDROGENÉTICA NO CARCINOMA DA PRÓSTATA Zenodo (CERN European Organization for Nuclear Research) · 2023
    27. How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss Skin appendage disorders · 2022
    28. Role of serum androgens and prostate-specific antigen levels in males with androgenetic alopecia Human Andrology · 2019
    29. Association between degrees of alopecia and prostate specific antigen level in men with androgenetic alopecia Journal of The American Academy of Dermatology · 2019
    30. Serum prostate spesific antigen levels in women with androgenetic alopecia Turkderm · 2019